Social Media / Digital Marketing

Pharma has been quick to take up its share of social media — companies have already staked out their space on Facebook, Twitter and even Pinterest.  Television ad spending is down as drug companies have increased their use of these new platforms to interact...

The pharmaceutical industry has begun to dabble in online business communication, especially around speaker programs aimed at informing healthcare providers of new research and medicines.  Of course, pharmaceutical speaker programs have existed for a while in...

Telemedicine — transmitting medical information from one location to another by electronic means — has been evolving since the advent of the Internet.  Forbes reports that 2002 studies showed patients are more forthcoming and more likely to provide physicians...

When it comes to medical information, pharmaceutical companies are often the last place patients look.  Patients consider pharma a secondary medical resource — if they consider it at all.  One consultant Cutting Edge Information recently interviewed explained...

Pharma continues to expand its use of social media.  As pharma’s understanding of social media has widened, its use of digital channels has broadened.  From Facebook to Twitter to Pinterest, these platforms may help companies promote disease awareness, spread...

A glance at the number of pharma-related mobile applications available on iTunes shows that mobile health has transcended its role beyond just another hot topic in healthcare.  These apps are increasingly popping up for all kinds of purposes ranging from patient...

The game has changed for many medical fields as digital technology has overtaken the world’s storage and communication systems.  Recently, I wrote about mobile health applications targeting patients through adherence programs.  But it turns out that physicians...

Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0.  Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drugs.  The diversified portfolio model of Pharma 2.0 is no longer...

The simple answer to this question is yes. Pharma has already produced a plethora of mobile and digital devices geared to both patient and physician perspectives. With the accessibility of these versatile apps, pharma’s targets continue to demand more. While...

As pharma companies broaden their technological horizons, mHealth is proving a viable and valuable digital strategy. Mobile health initiatives span many different channels and levels of patient and physician accessibility. Consequently, they are subject to varying...